The Clinical Significance of Promoter Methylation of Fluoropyrimidine Metabolizing and Cyclooxygenase Genes in Colorectal Cancer

por Fouad, Mariam Ahmed, Salem, Salem Eid, Hussien, Marwa M., Badr, Doaa Mohamed, Zekri, Abdelrahman N., Hafez, Hafez Farouk, Shouman, Samia A.
Publicado 2021

The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial

por Karkeet, Riham M., Zekri, Abdelrahman N., Sayed-Ahmed, Mohamed M., Sherif, Ghada M., Salem, Salem E., Abdelbary, Ahmed, Fouad, Mariam A., Saad, Sherif Y.
Publicado 2022

Fluoropyrimdine therapy induced alterations in interleukins expression in colorectal cancer patients

por Fouad, Mariam A, Salem, Salem E, Osman, Afaf S, Badr, Doaa M, Hussein, Marwa M, Zekri, Abdelrahman N, Hafez, Hafez F, Kamel, Mahmoud M, Shouman, Samia A
Publicado 2021